Skip to main content
    V

    Vor Biopharma Inc (VOR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $18.97
    -0.45 (-2.32%)

    Market Cap: $1.19B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vor Biopharma Inc (VOR) Earnings: Report Dates and Results

    Updated Oct 30, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Vor Biopharma (VOR) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Vor Biopharma reported EPS of -$0.90, below the -$0.81 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    36%(8/22)
    Avg Surprise
    -5.37%

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.95
    Range-$1.17 - -$0.78
    11 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.99
    Range-$0.99 - -$0.99
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.99
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    VOR has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, VOR beat 8, missed 13 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 43.46% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.90-$0.81N/A-11.11%MissN/A11 up, 1 downOct 30, 2026
    Jun 30, 2026-$0.80-$0.69-$0.82 - -$0.59-15.94%MissN/A21 up, 2 downAug 11, 2026
    Mar 31, 2026-$0.73-$0.78-$0.88 - -$0.69+6.41%BeatN/A43 up, 0 downMay 13, 2026
    Dec 31, 2025$307.53-$1.19-$1.90 - -$0.44N/AN/AN/A6N/AMar 30, 2026
    Sep 30, 2025-$121.63-$4.10-$4.22 - -$3.98N/AN/AN/A20 up, 0 downNov 13, 2025
    Jun 30, 2025-$251.20-$236.00N/A-6.44%MissN/A30 up, 1 downAug 12, 2025
    Mar 31, 2025-$5.20-$4.16-$5.00 - -$2.60-25.00%MissN/A52 up, 1 downMay 14, 2025
    Dec 31, 2024-$0.44-$0.31-$0.36 - -$0.20-43.46%MissN/A60 up, 0 downMar 20, 2025
    Sep 30, 2024-$8.00-$8.00-$8.80 - -$7.200.00%In lineN/A90 up, 0 downNov 7, 2024
    Jun 30, 2024-$8.20-$8.29-$9.40 - -$7.20+1.09%BeatN/A90 up, 0 downAug 8, 2024
    Mar 31, 2024-$9.00-$7.63-$8.40 - -$6.80-17.96%MissN/A90 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.39-$0.50-$0.53 - -$0.46+22.00%BeatN/A90 up, 0 downMar 20, 2024
    Sep 30, 2023-$9.80-$9.17-$9.80 - -$8.60-6.87%MissN/A90 up, 0 downNov 7, 2023
    Jun 30, 2023-$9.00-$8.46-$9.20 - -$7.80-6.38%MissN/A90 up, 0 downAug 10, 2023
    Mar 31, 2023-$8.60-$7.77-$8.40 - -$7.20-10.68%MissN/A80 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.52-$0.60-$0.81 - -$0.38+13.33%BeatN/A80 up, 0 downMar 23, 2023
    Sep 30, 2022-$12.60-$11.89-$14.00 - -$11.40-5.97%MissN/A80 up, 0 downNov 10, 2022
    Jun 30, 2022-$11.60-$13.00N/A+10.77%BeatN/AN/A0 up, 0 downAug 11, 2022
    Mar 31, 2022-$12.20-$10.29-$11.60 - -$8.60-18.56%MissN/A70 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.48-$0.57-$0.74 - -$0.51+15.79%BeatN/A70 up, 0 downMar 14, 2022
    Sep 30, 2021-$10.00-$11.50-$16.80 - -$10.20+13.04%BeatN/A40 up, 0 downNov 10, 2021
    Jun 30, 2021-$10.00-$9.27-$11.80 - -$7.60-7.87%MissN/A4N/AAug 9, 2021
    Mar 31, 2021-$13.40-$15.20-$16.20 - -$8.60+11.84%BeatN/A3N/AMay 6, 2021
    Dec 31, 2020-$217.49-$4.40N/AN/AN/AN/A2N/AMar 25, 2021
    Sep 30, 2020-$7.26-$5.33N/A-36.21%MissN/AN/AN/ADec 18, 2020
    Jun 30, 2020-$4.67N/AN/AN/AN/AN/AN/AN/ASep 30, 2020
    Mar 31, 2020-$4.14N/AN/AN/AN/AN/AN/AN/AJun 30, 2020
    Dec 31, 2019-$4.14N/AN/AN/AN/AN/AN/AN/AMar 30, 2020
    Jun 30, 2019-$2.62N/AN/AN/AN/AN/AN/AN/ASep 30, 2019
    Mar 31, 2019-$1.33N/AN/AN/AN/AN/AN/AN/AJun 29, 2019
    Dec 31, 2018-$1.33N/AN/AN/AN/AN/AN/AN/AMar 30, 2019
    Last 31 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$70.50, after -$25.64 the year before. It was -$1.33 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$70.50N/A
    Dec 31, 2024-$25.64N/A
    Dec 31, 2023-$27.79N/A
    Dec 31, 2022-$36.92N/A
    Dec 31, 2021-$33.88N/A
    Dec 31, 2020-$233.56N/A
    Dec 31, 2019-$8.08N/A
    Dec 31, 2018-$1.33N/A

    Frequently Asked Questions About VOR

    When is Vor Biopharma's next earnings date?

    Vor Biopharma's next earnings report is expected for Mar 29, 2027.

    Did VOR beat earnings estimates last quarter?

    No. Vor Biopharma reported EPS of -$0.90 for the quarter ended Sep 30, 2026, below the -$0.81 estimate by 11.11%.

    What EPS do analysts expect from VOR next quarter?

    The consensus EPS estimate for Vor Biopharma for the quarter ending Dec 31, 2026 is -$0.95 from 11 analysts, with estimates from -$1.17 to -$0.78.

    How often does VOR beat earnings estimates?

    Vor Biopharma beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -11.81%.